ARTICLE | Company News
ChemoCentryx, GlaxoSmithKline deal
May 11, 2009 7:00 AM UTC
ChemoCentryx received a $5 million milestone payment from GlaxoSmithKline under a 2006 deal that gave the pharma an option to preclinical programs against chemokine and chemoattractant receptors. The ...